RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
RAPT is expected to report earnings to fall 89.38% to -12 cents per share on May 08
Q1'25
Est.
$-0.12
Q4'24
Missed
by $0.82
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.01
Q1'24
Beat
by $0.02
The last earnings report on March 06 showed earnings per share of -113 cents, missing the estimate of -31 cents. With 483.57K shares outstanding, the current market capitalization sits at 139.93M.